Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1984 1
1985 2
1988 1
1990 1
1991 10
1992 6
1993 16
1994 24
1995 19
1996 27
1997 41
1998 28
1999 33
2000 29
2001 32
2002 33
2003 36
2004 35
2005 39
2006 41
2007 40
2008 43
2009 30
2010 43
2011 44
2012 52
2013 36
2014 44
2015 49
2016 27
2017 34
2018 29
2019 28
2020 22
Text availability
Article attribute
Article type
Publication date

Search Results

901 results
Results by year
Filters applied: . Clear all
Page 1
Management of hepatitis B and C infections in rheumatologic disease.
Cheah JT, Faragon JJ, Marks KM. Cheah JT, et al. Best Pract Res Clin Rheumatol. 2018 Dec;32(6):848-868. doi: 10.1016/j.berh.2019.04.001. Best Pract Res Clin Rheumatol. 2018. PMID: 31427059 Review.
Hepatitis B and C viruses present dual considerations in rheumatic disease as both etiologic factors and important comorbidities that must be assessed and addressed. This review summarizes the link between hepatitis B and arthritis and polyarteritis no
Hepatitis B and C viruses present dual considerations in rheumatic disease as both etiologic factors and important comorbiditi
Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy.
Chen YM, Huang WN, Liao TL, Chen JP, Yang SS, Chen HH, Hsieh TY, Hung WT, Chen YH, Chen DY. Chen YM, et al. Ann Rheum Dis. 2019 Jun;78(6):849-850. doi: 10.1136/annrheumdis-2018-214400. Epub 2019 Jan 3. Ann Rheum Dis. 2019. PMID: 30606739 No abstract available.
Considering hepatitis C virus infection as a systemic disease.
Cacoub P, Comarmond C. Cacoub P, et al. Semin Dial. 2019 Mar;32(2):99-107. doi: 10.1111/sdi.12758. Epub 2018 Dec 13. Semin Dial. 2019. PMID: 30549107 Free article. Review.
Hepatitis C virus (HCV) infection has been demonstrated to result in several adverse hepatic outcomes and has been associated with a number of important extrahepatic manifestations. The scope of extrahepatic clinical possibilities includes systemic diseases such as
Hepatitis C virus (HCV) infection has been demonstrated to result in several adverse hepatic outcomes and has been associated
Prevalence and correlates of hepatitis C virus-associated inflammatory arthritis in a population-based cohort.
Ferucci ED, Choromanski TL, Varney DT, Ryan HS, Townshend-Bulson LJ, McMahon BJ, Wener MH. Ferucci ED, et al. Semin Arthritis Rheum. 2017 Dec;47(3):445-450. doi: 10.1016/j.semarthrit.2017.04.004. Epub 2017 Apr 24. Semin Arthritis Rheum. 2017. PMID: 28532574
OBJECTIVES: The objectives of this study were to determine the prevalence of hepatitis C virus-associated inflammatory arthritis, to describe its clinical and immunologic correlates, and to identify features that are characteristic of arthritis in chro …
OBJECTIVES: The objectives of this study were to determine the prevalence of hepatitis C virus-associated inflammatory arth
Cryoglobulinaemia.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2018 Aug 2;4(1):12. doi: 10.1038/s41572-018-0015-6. Nat Rev Dis Primers. 2018. PMID: 30072792 Review. No abstract available.
Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.
Younossi Z, Park H, Henry L, Adeyemi A, Stepanova M. Younossi Z, et al. Gastroenterology. 2016 Jun;150(7):1599-1608. doi: 10.1053/j.gastro.2016.02.039. Epub 2016 Feb 26. Gastroenterology. 2016. PMID: 26924097 Review.
BACKGROUND & AIMS: Hepatitis C virus (HCV) infection has hepatic and extrahepatic manifestations with various costs and impairments to health-related quality of life (HRQL). ...METHODS: We performed systematic reviews of the literature using MEDLINE, CINAHL, and …
BACKGROUND & AIMS: Hepatitis C virus (HCV) infection has hepatic and extrahepatic manifestations with various costs and im …
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis.
Sebastiani M, Milazzo L, Atzeni F, Vacchi C, Manfredi A, Quartuccio L, Scirè C, Gaeta GB, Lapadula G, Armignacco O, Tavio M, D'Angelo S, Meroni P, Bazzichi L, Grassi W, Mathieu A, Mastroianni C, Sagnelli E, Santantonio T, Foppa CU, Puoti M, Sarmati L, Airò P, Epis OM, Scrivo R, Gargiulo M, Riva A, Ciancio G, Zehender G, Taliani G, Meroni L, Sollima S, Sarzi-Puttini P, Galli M. Sebastiani M, et al. Mod Rheumatol. 2019 Nov;29(6):895-902. doi: 10.1080/14397595.2018.1558918. Epub 2019 Jan 22. Mod Rheumatol. 2019. PMID: 30582388
Objectives: The recent introduction of direct-acting antiviral agents (DAAs) which can eliminate Hepatitis C virus (HCV) had revolutionized the treatment of HCV infections also in a complex clinical setting such as the patients with rheumatoid arthritis (RA). …
Objectives: The recent introduction of direct-acting antiviral agents (DAAs) which can eliminate Hepatitis C virus (HCV) had r …
Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
Zengin O, Yıldız H, Demir ZH, Dağ MS, Aydınlı M, Onat AM, Kısacık B. Zengin O, et al. Adv Clin Exp Med. 2017 Sep;26(6):987-990. doi: 10.17219/acem/63095. Adv Clin Exp Med. 2017. PMID: 29068601 Free article.
Hepatitis B virus (HBV), a member of the family Hepadnaviridae and hepatitis C virus (HCV), play an important role in the undetermined etiology of arthritis. ...MATERIAL AND METHODS: Forty-four patients with hepatitis B, 43 patients with hepa
Hepatitis B virus (HBV), a member of the family Hepadnaviridae and hepatitis C virus (HCV), play an important role in t
Rituximab May Cause Increased Hepatitis C Virus Viremia in Rheumatoid Arthritis Patients Through Declining Exosomal MicroRNA-155.
Liao TL, Hsieh SL, Chen YM, Chen HH, Liu HJ, Lee HC, Chen DY. Liao TL, et al. Arthritis Rheumatol. 2018 Aug;70(8):1209-1219. doi: 10.1002/art.40495. Epub 2018 Jun 27. Arthritis Rheumatol. 2018. PMID: 29575671 Free article.

A significantly greater decrement of exo-miR-155 expression was observed after rituximab therapy compared with those observed before therapy (P < 0.01), and hepatitis C viral loads increased simultaneously (P < 0.05). CONCLUSION: Circulating exo-miR-155 levels

A significantly greater decrement of exo-miR-155 expression was observed after rituximab therapy compared with those observed before therapy …
How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.
Brito-Zerón P, Gheitasi H, Retamozo S, Bové A, Londoño M, Sánchez-Tapias JM, Caballero M, Kostov B, Forns X, Kaveri SV, Ramos-Casals M. Brito-Zerón P, et al. Arthritis Res Ther. 2015 Sep 10;17(1):250. doi: 10.1186/s13075-015-0766-3. Arthritis Res Ther. 2015. PMID: 26370711 Free PMC article.
INTRODUCTION: We conducted a study to analyze how infection by hepatitis C virus (HCV) may influence the immunological serum pattern of patients with Sjögren syndrome (SS). ...
INTRODUCTION: We conducted a study to analyze how infection by hepatitis C virus (HCV) may influence the immunological serum p …
901 results
Jump to page
Feedback